Cairo – Mubasher: The ordinary general meeting (OGM) of October Pharma approved a cash dividend of 30% of the capital or EGP 3 per share for 2020.
The shareholders also decided to postpone the issuance of bonus shares for further consideration, the company said in a bourse disclosure on Sunday.
In March, the board of directors recommended distributing cash dividends of EGP 3 per share as well as two bonus shares for every share held for 2020.
In 2020, the company logged net profits of EGP 88.26 million, up from EGP 33.8 million a year earlier.
